Humana Extends Slide as Piper Sandler Downgrades on Star Ratings Update
Humana Cut to Neutral From Overweight by Piper Sandler
Bernstein Maintains Humana(HUM.US) With Hold Rating, Cuts Target Price to $405
Piper Sandler Downgrades Humana(HUM.US) to Hold Rating, Cuts Target Price to $274
Deutsche Bank Maintains Humana(HUM.US) With Hold Rating, Announces Target Price $250
Humana (HUM) Receives a Hold From Deutsche Bank
A Quick Look at Today's Ratings for Humana(HUM.US), With a Forecast Between $247 to $402
Humana Is Maintained at Outperform by Oppenheimer
Truist Financial Releases a Hold Rating on Humana (HUM)
Oppenheimer Adjusts Price Target on Humana to $280 From $400, Maintains Outperform Rating
Humana's Star Rating Decline Prompts Hold Rating Amid Financial Uncertainty
Buy Rating Affirmed: Humana's Proactive Strategies to Mitigate Earnings Headwinds
Humana Downgraded to Underperform at BofA After Loss of Leading Star Position
Humana Analyst Ratings
Humana Price Target Cut to $250.00/Share From $400.00 by Leerink Partners
J.P. Morgan Weighs in on Humana Stock Following Medicare Star Rating Changes
Humana Downgraded to Market Perform at Leerink on Lower Recovery Visibility
Home Depot Upgraded, Humana Downgraded: Wall Street's Top Analyst Calls
Humana Downgraded to Equal Weight From Overweight at Stephens
Stephens Downgrades Humana to Equalweight From Overweight, Cuts Price Target to $250 From $400